Standard
Breakthrough in Neuroinflammation: Researchers Identify Existing Drug Target to Combat Brain Disorders
In a significant advancement for neurological medicine, researchers at the University of Birmingham have unveiled a promising new strategy to curb harmful inflammation in the brain. By pinpointing a specific receptor—the P2X7 receptor—that acts as a primary catalyst for neuroinflammatory responses, the team has identified a potential therapeutic pathway that could be addressed using existing…
